Idoroenyi Amanam

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 16 papers. Top paper: “Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimens”.

Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimens

Bone Marrow Transplantation(2021)10.1038/s41409-021-01528-y

N/A

0.549DataRank · unranked

9 citations

Dongyun Yang, Mary C. Clark, Salman Otoukesh, Thai M. Cao, Haris Ali +13 more

TP53 mutations are associated with CD19− relapse and inferior outcomes after blinatumomab in adults with ALL

Blood Advances(2025)10.1182/bloodadvances.2024014986

N/A

0.449DataRank · unranked

19 citations

Shanpeng Li, Jianying Zhang, Mary C. Clark, Vaibhav Agrawal, Hoda Pourhassan +25 more

Role of ROCK2 inhibitors in the treatment of chronic graft-versus-host disease

Expert Opinion on Investigational Drugs(2025)10.1080/13543784.2025.2510667

N/A

0.312DataRank · unranked

7 citations

Jose Tinajero, Salman Otoukesh, Karamjeet Sandhu, Haris Ali, Shukaib Arslan +5 more

Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD)

Cancers(2024)10.3390/cancers16233912

N/A

0.104DataRank · unranked

1 citations

Tina Nguyen, Dongyun Yang, Salman Otoukesh, Shukaib Arslan, Amanda Blackmon +19 more

Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.05.008

N/A

0DataRank · unranked

10 citations

Salman Otoukesh, Hanna Kim, Dongyun Yang, Sally Mokhtari, Yazeed Samara +21 more

Risk prediction for clonal cytopenia: multicenter real-world evidence

Blood(2024)10.1182/blood.2024024756

N/A

0DataRank · unranked

50 citations

Rami S. Komrokji, Najla Al‐Ali, Alexandra Regelson, Susan Geyer, Anand Patel +39 more

IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cells

Journal of Hematology & Oncology(2024)10.1186/s13045-024-01586-x

N/A

0DataRank · unranked

19 citations

Miso Park, Lucy Ghoda, Dandan Zhao, Melissa Valerio, Ebtesam Nafie +19 more

Total Body Irradiation and Fludarabine with Post-Transplantation Cyclophosphamide for Mismatched Related or Unrelated Donor Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.08.005

N/A

0DataRank · unranked

3 citations

Amrita Desai, Dongyun Yang, Sally Mokhtari, Katrin Tiemann, Salman Otoukesh +22 more

Precision medicine and actionable alterations in lung cancer: A single institution experience

PLoS ONE(2020)10.1371/journal.pone.0228188

N/A

0DataRank · unranked

9 citations

Yingyu Wang, Chen Chen, Sorena Nadaf, Rebecca Pharaon, Jeremy Fricke +19 more

Comparing transplant outcomes in ALL patients after myeloablative conditioning in mismatch-related or unrelated donor settings

Bone Marrow Transplantation(2024)10.1038/s41409-024-02378-0

N/A

0DataRank · unranked

0 citations

Dongyun Yang, Sally Mokhtari, Hoda Pourhassan, Vaibhav Agrawal, Shukaib Arslan +21 more

Fludarabine melphalan reduced intensity conditioning vs radiation-based myeloablative conditioning in patients undergoing allogeneic transplantation for acute myeloid leukemia with measurable residual disease

Bone Marrow Transplantation(2024)10.1038/s41409-024-02491-0

N/A

0DataRank · unranked

0 citations

Michelle Afkhami, Dongyun Yang, Sally Mokhtari, Yazeed Samara, Hoda Pourhassan +23 more

High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia‐like fusions

American Journal of Hematology(2023)10.1002/ajh.26908

N/A

0DataRank · unranked

17 citations

Michelle Afkhami, Dongyun Yang, Zhaohui Gu, Sally Mokhtari, Shilpa Shahani +25 more

Impact of hyperhydration on fluid overload and hematopoietic cell transplant after post-transplant cyclophosphamide-based graft-versus-host-disease prophylaxis

Frontiers in Immunology(2025)10.3389/fimmu.2025.1543099

N/A

0DataRank · unranked

4 citations

Janny M. Yao, Yazeed Samara, Dongyun Yang, Sally Mokhtari, Katrin Tiemann +25 more

Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis

Bone Marrow Transplantation(2025)10.1038/s41409-025-02738-4

N/A

0DataRank · unranked

1 citations

Dongyun Yang, Monzr M. Al Malki, Sally Mokhtari, Diana Knobler, Vaibhav Agarwal +21 more

Outcomes after Melphalan-Based Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Renal Impairment

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.07.001

N/A

0DataRank · unranked

0 citations

Tanya Markary, Ni-Chun Tsai, Katrin Tiemann, Sally Mokhtari, Yazeed Samara +24 more

Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival

Journal of Thoracic Disease(2020)10.21037/jtd.2020.04.18

N/A

0DataRank · unranked

46 citations

Isa Mambetsariev, Rohan Gupta, Srisairam Achuthan, Yingyu Wang, Rebecca Pharaon +5 more